The National Health Service (Pharmaceutical Services) Regulations 2005

Notification of applications

23.—(1) This regulation applies where a Primary Care Trust receives an application which falls to be dealt with as mentioned in regulation 6, 7 or 22(1).

(2) Subject to regulations 25 and 26, the Primary Care Trust shall, as soon as is practicable, give notice in writing of the application to—

(a) the Local Pharmaceutical Committee;

(b) the Local Medical Committee;

(c) any person who is included in a pharmaceutical list and whose interests might, in the opinion of the Primary Care Trust, be significantly affected if the application were granted;

(d) any LPS chemist whose interests might, in the opinion of the Primary Care Trust, be significantly affected if the application were granted;

(e) any Primary Care Trust or Local Health Board any part of whose area is within two kilometres of the premises;

(f) any Patients' Forum serving the area of the Primary Care Trust; and

(g) any other patient, consumer or community groups in the area of the Primary Care Trust that the Primary Care Trust considers has an interest in the provision of pharmaceutical services in the neighbourhood,

and any person so notified may, within 45 days from the date on which the notification was sent, or such longer period as the Primary Care Trust may allow in its notification, make representations in writing to the Primary Care Trust.

(3) A Primary Care Trust or Local Health Board which is notified under paragraph (2)(e) shall, as soon as is practicable, give notice in writing of the application to—

(a) the Local Pharmaceutical Committee for its area;

(b) the Local Medical Committee for its area;

(c) any person whose name is included in a pharmaceutical list and whose interests might, in the opinion of that Primary Care Trust or Local Health Board, be significantly affected if the application were granted;

(d) any LPS chemist whose interests might, in the opinion of that Primary Care Trust, be significantly affected if the application were granted;

(e) any Patients' Forum or Community Health Council serving its area; and

(f) any other patient, consumer or community groups in the area that the Primary Care Trust or Local Health Board considers has an interest in the provision of pharmaceutical services in the neighbourhood,

and any person so notified may, within 45 days from the date on which the notification was sent, make representations in writing to the Primary Care Trust to which the application was made.

(4) Any notice given under paragraph (2) or (3) shall include a notification of the right to make representations in accordance with that paragraph.